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Atypical antipsychotic drugs have now become the lead-
ing drug therapy for patients with schizophrenia and
other related psychotic disorders. Atypical antipsychotic
drugs differ form typical antipsychotic drugs in that they
are both more effective, especially for negative symptoms
and cognitive deficits, and better tolerated. Perhaps the
first atypical antipsychotic drug was clozapine, whose
mechanism of action is complex (i.e., antagonist action at
various monoamine receptors, especially serotonin recep-
tors), and remains under investigation. For several other
atypical drugs, such as risperidone, olanzapine, quetiap-
ine and ziprasidone, their atypical characteristics are
attributed to blockade of serotonin (5-HT2A) receptors as
well as dopamine (D2) receptors. Recently, aripiprazole
was introduced into clinical use, and appears to have atyp-
ical properties as well. However, in the case of this drug,
the atypical properties are attributed to its actions as a par-
tial agonist at the dopamine (D2) receptor. Aripiprazole
has several clinical advantages over other antipsychotic
drugs including minimal metabolic as well as neurologi-
cal side-effects. Further, aripiprazole's mechanism of
action is unique among both typical and atypical antipsy-
chotic drugs, which suggests that it should is the prototype
for a new class of antipsychotic drug.
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